HCA Healthcare, Inc. $HCA Shares Bought by Rakuten Investment Management Inc.

Rakuten Investment Management Inc. grew its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 2,225.6% during the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 21,186 shares of the company’s stock after purchasing an additional 20,275 shares during the quarter. Rakuten Investment Management Inc.’s holdings in HCA Healthcare were worth $10,043,000 as of its most recent filing with the SEC.

Several other large investors have also modified their holdings of HCA. Norges Bank bought a new stake in shares of HCA Healthcare during the 4th quarter worth $1,262,513,000. Life Cycle Investment Partners Ltd bought a new stake in shares of HCA Healthcare during the 4th quarter worth $374,037,000. Viking Global Investors LP boosted its stake in shares of HCA Healthcare by 58.5% during the 2nd quarter. Viking Global Investors LP now owns 1,872,133 shares of the company’s stock worth $717,214,000 after acquiring an additional 690,773 shares in the last quarter. Northwestern Mutual Wealth Management Co. boosted its stake in shares of HCA Healthcare by 4,545.5% during the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 663,337 shares of the company’s stock worth $309,686,000 after acquiring an additional 649,058 shares in the last quarter. Finally, Danske Bank A S bought a new stake in shares of HCA Healthcare during the 3rd quarter worth $115,530,000. 62.73% of the stock is owned by institutional investors.

HCA Healthcare Trading Up 1.7%

Shares of NYSE:HCA opened at $396.55 on Wednesday. HCA Healthcare, Inc. has a 1 year low of $330.00 and a 1 year high of $556.52. The business has a fifty day simple moving average of $426.45 and a 200 day simple moving average of $471.57. The firm has a market cap of $87.97 billion, a price-to-earnings ratio of 13.64, a P/E/G ratio of 1.24 and a beta of 1.12.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings data on Friday, April 24th. The company reported $7.15 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.19 by ($0.04). HCA Healthcare had a negative return on equity of 295.93% and a net margin of 8.89%.The firm had revenue of $19.11 billion for the quarter, compared to analysts’ expectations of $19.09 billion. During the same quarter in the prior year, the business posted $6.45 earnings per share. HCA Healthcare’s revenue was up 4.3% on a year-over-year basis. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. On average, sell-side analysts forecast that HCA Healthcare, Inc. will post 30.07 EPS for the current year.

HCA Healthcare Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, June 30th. Shareholders of record on Tuesday, June 16th will be issued a dividend of $0.78 per share. This represents a $3.12 annualized dividend and a yield of 0.8%. The ex-dividend date is Tuesday, June 16th. HCA Healthcare’s dividend payout ratio (DPR) is 10.73%.

Analyst Ratings Changes

Several brokerages have recently commented on HCA. Stephens decreased their target price on HCA Healthcare from $560.00 to $530.00 and set an “overweight” rating for the company in a research report on Monday, April 27th. Jefferies Financial Group reaffirmed a “buy” rating and issued a $525.00 target price on shares of HCA Healthcare in a research report on Friday, April 24th. TD Cowen decreased their target price on HCA Healthcare from $561.00 to $500.00 and set a “buy” rating for the company in a research report on Monday, April 27th. KeyCorp decreased their target price on HCA Healthcare from $550.00 to $510.00 and set an “overweight” rating for the company in a research report on Monday, April 27th. Finally, Oppenheimer decreased their target price on HCA Healthcare from $540.00 to $520.00 and set an “outperform” rating for the company in a research report on Monday, April 27th. Fifteen investment analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $506.14.

About HCA Healthcare

HCA Healthcare is a for?profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.